ClinicalTrials.gg
RecruitingNCT06540222SUCCECSUpdated Oct 29, 2026

Sustained Cord Circulation at Emergency Cesarean Section

An interventional study of Sustained cord (≥ 180 seconds) resuscitation and Routine (< 60 seconds) cord clamping in Asphyxia Neonatorum and Fetal Hypoxia, sponsored by Region Skane. Recruiting at 12 sites in Sweden. Open to participants aged 37 Weeks to 42 Weeks. Per ClinicalTrials.gov, last updated 2026-10-29.

Sponsored by Region Skane · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.
Updated Oct 29, 2026Eligibility revisedPrimary outcomes revisedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
2,200
Allocation
Randomized
Ages
37 Weeks to 42 Weeks
Sex
All
01

Study summary

The goal of this clinical trial is to evaluate if sustained cord circulation during resuscitation improves outcomes for term neonates born by emergency Cesarean section. The main question it aims to answer is: Does sustained cord circulation reduce admission rates to neonatal care?

Researchers will compare resuscitation with an uncut umblical cord to standard resuscitation practices to see if it provides better outcomes.

Participants (term neonates born by emergency Cesarean section) will:

Receive resuscitation with either sustained cord circulation or standard care Be monitored for admission to neonatal care and other predefined health outcomes

Read the detailed description

Study Title

Sustained Cord Circulation at Emergency Cesarean Section (SUCCECS): A Multicenter Stepped-Wedge Cluster Randomized Trial

Primary Objectives:

To compare neonatal outcomes between two different approaches to resuscitation of term neonates born by CS; Intact cord resuscitation versus standard care with immediate cord clamping, and evaluate:

A composite outcome of admission to neonatal care before 72 completed hours of age meeting predefined criteria, or neonatal death before 72 completed hours of age regardless of admission. Predefined criteria include asphyxia at birth, respiratory distress, hypoxic ischemic encephalopathy (HIE) and hypoglycemia.

Secondary Objectives: Secondary outcomes will include short and long-term neonatal outcomes, adverse maternal and neonatal outcomes, and caregivers' and staff's experiences.

Study Design: A multicenter, stepped-wedge cluster randomized trial.

Study Population: Singleton neonate born alive, gestational age ≥37 weeks, born by emergency cesarean section, epidural/spinal anesthesia. Pediatric team summoned before birth due to health concerns regarding the neonate.

Intervention: Resuscitation with intact cord circulation during 3-5 minutes. When in need of respiratory support, the neonate will be kept close to the mother with the cord intact and the placenta attached to the uterine wall. The pediatric team will give respiratory support with sustained cord circulation, following Swedish neonatal CPR guidelines. Cord clamping will be performed after respiration has been established and at the earliest after three minutes. Cord clamping will be performed at the latest at 5 minutes.

Control: Resuscitation will be performed after the cord was cut. When in need of respiratory support, the cord will be clamped immediately, and the neonate will be taken to an adjacent place for resuscitation according to Swedish neonatal CPR guidelines. Well neonates will have their cord clamped after 1 minute in accordance with national recommendations.

Sample size: Planning assumptions were a pre-trial incidence of the primary outcome of 18.2%, an anticipated relative risk of 0.85 and a two-sided alpha of 0.05. The expected analyzable sample is approximately 2,200 neonates.

Study duration: inclusion from 8 September 2025 to 31 October 2027; follow-up to 48 months of age.

Outcome definitions and the statistical analysis plan were updated in Protocol version 2.2 and Statistical Analysis Plan version 2.0 (September 2026), before any interim analysis.

02

Conditions studied

  • Asphyxia Neonatorum
  • Fetal Hypoxia

Keywords

  • Emergency cesarean section
  • Management umbilical cord
  • intact cord resuscitation
03

In context

Asphyxia Neonatorum

106 studies on the registry are indexed under Asphyxia Neonatorum; 19 are open to participants now.

This study's planned enrollment of 2,200 is above the median of 173 across 73 interventional studies indexed under Asphyxia Neonatorum.

Browse Asphyxia Neonatorum studies →

Lead sponsor

Region Skane is the lead sponsor of 386 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Oct 29, 2026. See what changed

Ages eligible
37 Weeks to 42 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Singleton neonate
  • Born alive
  • Gestational age ≥37 weeks
  • Born by emergency cesarean section, epidural/spinal anesthesia, where the pediatric team was summoned before the start of the cesarean section because of health concerns regarding the neonate.

Exclusion criteria

Exclusion Criteria:

  • Major congenital malformation that may affect resuscitation or outcome measures.
  • Major genetic disorder that may affect resuscitation or outcome measures.
  • Condition in the mother or neonate, known before birth, that warrants immediate cord clamping (e.g., placenta accreta, severe maternal coagulation disorder).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
2,200 participants (estimated)

Study arms

  • Experimental
    Intact cord

    The neonate will be kept close to the mother with the cord intact. When in need of ventilatory support, the neonatal team will give ventilatory support with an unclamped umbilical cord, following neonatal cardiopulmonary resuscitation guidelines. Cord clamping will be performed after respiration has been established and at the earliest after three minutes and not later than five minutes.

    Procedure: Sustained cord (≥ 180 seconds) resuscitation

  • Active comparator
    Standard care

    Management according to standard care, including immediate cord clamping for neonates requiring ventilatory support. In cases where ventilatory support is not necessary, cord clamping will be performed within 60 seconds of birth, adhering to established clinical guidelines for neonatal management.

    Procedure: Routine (< 60 seconds) cord clamping

Interventions

  • ProcedureSustained cord (≥ 180 seconds) resuscitation

    Resuscitation performed in near proximity to the mother with umbilical cord uncut

    Also known as: Intact cord resuscitation, Delayed cord clamping

  • ProcedureRoutine (< 60 seconds) cord clamping

    Resuscitation performed at a designated area after umbilical cord is cut

    Also known as: Immediate clamping

06

What researchers measure

Primary outcomes

  1. Composite outcome of admission to neonatal care meeting predefined criteria or neonatal death, before 72 completed hours of age.

    Binary composite. Event: (1) admission to neonatal care before 72 completed hours of age with at least one predefined criterion, or (2) death of a liveborn neonate before 72 completed hours of age (days 0-2), regardless of admission. Criteria: asphyxia at birth (Apgar score \<4 at 1 minute, \<4 at 5 minutes or \<6 at 10 minutes; Apgar values are taken from the Swedish Pregnancy Register (SPR); the Swedish Neonatal Quality Register (SNQ) value is used only when the SPR value is missing); respiratory morbidity (ICD-10 P22.0, P22.1, P22.8, P24.0, P25.1 or P29.3B); hypoxic-ischemic encephalopathy grade I-III (P91.6A, P91.6B, P91.6C or P91.6X); hypoglycemia (P70.4A or P70.4B). Admissions and diagnoses from SPR and SNQ; deaths additionally from Statistics Sweden, including deaths after discharge.

    Time frame: From birth to 72 completed hours of age (days 0-2)

Secondary outcomes

  1. Apgar score at 5 min

    Assessed by staff, composite of heart rate, breathing effort, skin color, muscle tone and reflexes, each sub scale 0 (absent), 1, 2 (normal). Minimum 0, maximum 10. Less than 4 is a measure for severe asphyxia, less than 7 measure of mild asphyxia.

    Time frame: 5 minutes

  2. Apgar score at 10 min

    Assessed by staff, composite of heart rate, breathing effort, skin color, muscle tone and reflexes, each sub scale 0 (absent), 1, 2 (normal). Minimum 0, maximum 10. Less than 4 is a measure for severe asphyxia, less than 7 measure of mild asphyxia.

    Time frame: 10 minutes

  3. Respiratory distress as a diagnosis after birth

    Having the at least one of the following diagnosis in the Swedish neonatal quality registry: NAS, neonatal respiratory distress P22.8, PAS, pulmonary adaption disturbance P 22.1, RDS, respiratory distress syndrome P22.0, MAS meconium aspiration syndrome P24.0, PPHN, Persistent Pulmonary Hypertension P29.3B, or PTX, Pneumothorax P25.1.

    Time frame: From birth to 72 completed hours of age

  4. Hypoxic-ischemic encephalopathy as a diagnosis after birth

    Having the at least one of the following diagnosis in the Swedish neonatal quality registry: Hypoxic-ischemic encephalopathy grade I-III, P91.6A, B, C, or X.

    Time frame: From birth to 72 completed hours of age

  5. Hypoglycemia as a diagnosis after birth

    Having the at least one of the following diagnosis in the Swedish neonatal quality registry: Hypoglycemia, P 70.4A, or B.

    Time frame: From birth to 72 completed hours of age

  6. Duration of neonatal care

    Duration of neonatal care as noted in the Swedish pregnancy register and Swedish neonatal quality registry: Aggregated as day (continuous) and ≥ 2 days, dichotomous

    Time frame: One month

  7. Death before discharge from the initial birth hospitalization

    All-cause death from birth until discharge from the initial birth hospitalization, without an upper time limit. For neonates transferred between hospitals, vital status is ascertained through SPR and SNQ linkage.

    Time frame: From birth until discharge from the initial birth hospitalization, an average of 4 days

  8. Early neonatal death before 168 completed hours of age

    Death of a liveborn neonate before 168 completed hours of age (days 0-6).

    Time frame: From birth to 168 completed hours of age (days 0-6)

Other outcomes

  1. Neonatal outcomes - breathing

    After birth (data registered on the resuscitation chart or imported from monitor equipment): Initiation and establishment of breathing (Minutes and seconds)

    Time frame: Birth to one hour

  2. Neonatal outcomes - temperature

    After birth (data registered on the resuscitation chart, source data sheet or imported from monitor equipment): Temperature (degrees Celsius)

    Time frame: Birth to six hours

  3. Neonatal outcomes - interventions

    After birth (data registered on the resuscitation chart or imported from monitor equipment): Rate of Interventions (e.g. ventilation, intubation, chest compressions) noted on the resuscitation chart

    Time frame: Birth to one hour

  4. Neonatal outcomes - heart rate

    After birth (data registered on the resuscitation chart or imported from monitor equipment): Data from Heart rate and Oxygen saturation monitoring Unit of measure: Heart rate

    Time frame: Birth to 24 hours

  5. Neonatal outcomes - oxygen saturation

    After birth (data registered on the resuscitation chart or imported from monitor equipment): Data from Heart rate and Oxygen saturation monitoring Unit of measure: Oxygen saturation

    Time frame: Birth to 24 hours

  6. Neonatal outcome - hyperbilirubinemia and jaundice

    ICD-10 P58.3, P59.8 or P59.9 together with KVÅ procedure code DQ015, recorded in SPR and/or SNQ. Neonates with concurrent hemolytic disease codes P55.0, P55.1, P55.8 or P55.9 are excluded.

    Time frame: Birth to seven days

  7. Neonatal morbidity

    During neonatal care (diagnosis from registries): Neonatal seizures Neonatal infection Neonatal jaundice Intracranial hemorrhage Unit of measure: Diagnosis occurring in Swedish Neonatal Quality registry

    Time frame: Birth to one month

  8. Maternal outcomes - maternal death

    Maternal death from any cause within 42 days postpartum, ascertained from SPR and medical records.

    Time frame: Child's birth until 6 weeks

  9. Maternal outcomes - maternal blood loss

    Maternal blood loss (Amount of postpartum bleeding, ml) Severe post-partum hemorrhage (\> 1000 ml and \> 2000 ml)

    Time frame: Birth to one month

  10. Maternal outcomes - post-surgery infection

    Maternal infection diagnosed within 1 week postpartum (ICD-10 O86.0, O86.1 or O86.8), ascertained from SPR or the medical record.

    Time frame: From delivery to 1 week postpartum

  11. Development assessed by ASQ at 12 months of age

    Assessed by Ages and Stages Questionnaire (ASQ). Minimum 0, maximum 300. Consist of 30 questions answered Yes (10), Sometimes (5), Not Yet (0). Five sub scales with six questions each: Communication, Fine motor, Gross motor, Problem solving and Personal-Social. Worse outcome is considered mean minus 2 standard deviations. 'At risk' outcome is considered mean minus 1 standard deviations.

    Time frame: 12 months

  12. Development

    Assessed by Ages and Stages Questionnaire (ASQ). Minimum 0, maximum 300. Consist of 30 questions answered Yes (10), Sometimes (5), Not Yet (0). Five sub scales with six questions each: Communication, Fine motor, Gross motor, Problem solving and Personal-Social. Worse outcome is considered mean minus 2 standard deviations. 'At risk' outcome is considered mean minus 1 standard deviations.

    Time frame: 24 months

  13. Development

    Assessed by Ages and Stages Questionnaire (ASQ). Minimum 0, maximum 300. Consist of 30 questions answered Yes (10), Sometimes (5), Not Yet (0). Five sub scales with six questions each: Communication, Fine motor, Gross motor, Problem solving and Personal-Social. Worse outcome is considered mean minus 2 standard deviations. 'At risk' outcome is considered mean minus 1 standard deviations.

    Time frame: 36 months

  14. Development

    Assessed by Ages and Stages Questionnaire (ASQ). Minimum 0, maximum 300. Consist of 30 questions answered Yes (10), Sometimes (5), Not Yet (0). Five sub scales with six questions each: Communication, Fine motor, Gross motor, Problem solving and Personal-Social. Worse outcome is considered mean minus 2 standard deviations. 'At risk' outcome is considered mean minus 1 standard deviations.

    Time frame: 48 months

07

Study locations

12 of 12 sites recruiting
  • Östra sjukhuset - Sahlgrenska Universitetssjukhuset
    Gothenburg, Sweden
    Recruiting
    • Anders Elfvin · ContactSUCCECS@med.lu.se · +46 31-342 10 00
    • Verena Sengpiel · Contact
    • Anders Elfvin · Principal investigator
    • Verena Sengpiel · Principal investigator
  • Hallands sjukhus, Halmstad
    Halmstad, Sweden
    Recruiting
    • Anna Kasemo · ContactSUCCECS@med.lu.se · +4635131000
    • Anna Kasemo · Principal investigator
    • Sofia Stålnacke · Principal investigator
  • Universitetssjukhuset i Linköping
    Linköping, Sweden
    Recruiting
    • Thomas Abrahamsson · Principal investigator
    • Sara Carlhäll · Principal investigator
  • Skånes Universitetssjukhus
    Lund, Sweden
    Recruiting
    • Elisabeth Olhager · ContactSUCCECS@med.lu.se · 046-171000
    • Elisabeth Olhager · Principal investigator
    • Anna Bonnevier · Principal investigator
  • Skånes Universitetssjukhus, Malmö
    Malmö, Sweden
    Recruiting
    • Elisabeth Olhager · ContactSUCCECS@med.lu.se · 040-331000
    • Elisabeth Olhager · Principal investigator
    • Gisela Rickle · Principal investigator
  • Universitetssjukhuset Örebro
    Örebro, Sweden
    Recruiting
    • Miriam Pettersson · Principal investigator
    • Karin Hilden · Principal investigator
  • BB Stockholm
    Stockholm, Sweden
    Recruiting
    • Anna Claréus · Principal investigator
    • Katarina Remaeus · Principal investigator
  • Danderyds sjukhus
    Stockholm, Sweden
    Recruiting
    • Anna Claréus · Principal investigator
    • Sophia Brismar Wendel · Principal investigator
  • Karolinska Universitetssjukhuset, Huddinge
    Stockholm, Sweden
    Recruiting
    • Jenny Svedenkrans · Principal investigator
    • Johanna Andersson · Principal investigator
  • Karolinska Universitetssjukhuset, Solna
    Stockholm, Sweden
    Recruiting
    • Malin Kjellberg · Principal investigator
    • Anna Sand · Principal investigator
  • Södersjukhuset - Sachsska barn- och ungdomssjukhuset
    Stockholm, Sweden
    Recruiting
    • Jenny Bolk · Principal investigator
    • Julia Savchenko · Principal investigator
  • Norrlands universitetssjukhus
    Umeå, Sweden
    Recruiting
    • Magnus Domellöf · Principal investigator
    • Linnea Åström · Principal investigator
08

References and documents

Publications

  • Ekelof K, Saether E, Andersson O, Svedenkrans J, Linden K. pre-SUCCECS: Lessons learned from implementing resuscitation and stabilisation with an intact cord during caesarean sections - Focus group discussions with implementation teams. Sex Reprod Healthc. 2025 Sep;45:101114. doi: 10.1016/j.srhc.2025.101114. Epub 2025 May 26. PubMed 40479951 ↗
  • Alikhani VS, Thies-Lagergren L, Svedenkrans J, Elfvin A, Bolk J, Andersson O. Stabilisation and resuscitation with intact cord circulation is feasible using a wide variety of approaches; a scoping review. Acta Paediatr. 2023 Dec;112(12):2468-2477. doi: 10.1111/apa.16985. Epub 2023 Sep 28. PubMed 37767916 ↗

Individual participant data

Plan to share: No — At present we are not allowed to share anonymized data extracted from Swedish medical health registers.

09

Updates

1 registry update since Sep 25, 2026
Eligibility
1 inclusion criterion edited; 1 exclusion criterion added
What changed in the criteria
Inclusion criteria
  • EditedBorn by emergency cesarean section, epidural/spinal anesthesia, where the pediatric/neonatal team has been called for to attendwas summoned before the start of the cesarean section because of health concerns regarding the neonate.
Exclusion criteria
  • AddedCondition in the mother or neonate, known before birth, that warrants immediate cord clamping (e.g., placenta accreta, severe maternal coagulation disorder).
Oct 29, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedComposite outcome of admission to neonatal care formeeting predefined criteria andor neonatal death, before admission72 completed hours of age.Time frame: At one hour after birth → From birth to 72 completed hours of age (days 0-2)
Oct 29, 2026
Secondary outcomes
4 time frame changed, 2 added, 1 removed, 3 description edited
What changed in the outcomes
  • AddedDeath before discharge from the initial birth hospitalizationTime frame: From birth until discharge from the initial birth hospitalization, an average of 4 days
  • AddedEarly neonatal death before 168 completed hours of ageTime frame: From birth to 168 completed hours of age (days 0-6)
  • RemovedDeath after birth but before admission to neonatal unitTime frame: One hour after birth
  • Time frameRespiratory distress as a diagnosis after birthOne week after birth → From birth to 72 completed hours of age
  • Time frameHypoxic-ischemic encephalopathy as a diagnosis after birthOne week after birth → From birth to 72 completed hours of age
  • Time frameHypoglycemia as a diagnosis after birthOne week after birth → From birth to 72 completed hours of age
  • Time frameother outcomeMaternal outcomes - post-surgery infectionBirth to one month → From delivery to 1 week postpartum
  • Descriptionother outcomeMaternal outcomes - maternal death: how it is measured was reworded
  • Descriptionother outcomeMaternal outcomes - post-surgery infection: how it is measured was reworded
  • Descriptionother outcomeNeonatal outcome - hyperbilirubinemia and jaundice: how it is measured was reworded
Oct 29, 2026
Show all 1 update
  1. Oct 29, 2026
    Eligibility 1 inclusion criterion edited; 1 exclusion criterion added
    What changed in the criteria
    Inclusion criteria
    • EditedBorn by emergency cesarean section, epidural/spinal anesthesia, where the pediatric/neonatal team has been called for to attendwas summoned before the start of the cesarean section because of health concerns regarding the neonate.
    Exclusion criteria
    • AddedCondition in the mother or neonate, known before birth, that warrants immediate cord clamping (e.g., placenta accreta, severe maternal coagulation disorder).
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedComposite outcome of admission to neonatal care formeeting predefined criteria andor neonatal death, before admission72 completed hours of age.Time frame: At one hour after birth → From birth to 72 completed hours of age (days 0-2)
    Secondary outcomes 4 time frame changed, 2 added, 1 removed, 3 description edited
    What changed in the outcomes
    • AddedDeath before discharge from the initial birth hospitalizationTime frame: From birth until discharge from the initial birth hospitalization, an average of 4 days
    • AddedEarly neonatal death before 168 completed hours of ageTime frame: From birth to 168 completed hours of age (days 0-6)
    • RemovedDeath after birth but before admission to neonatal unitTime frame: One hour after birth
    • Time frameRespiratory distress as a diagnosis after birthOne week after birth → From birth to 72 completed hours of age
    • Time frameHypoxic-ischemic encephalopathy as a diagnosis after birthOne week after birth → From birth to 72 completed hours of age
    • Time frameHypoglycemia as a diagnosis after birthOne week after birth → From birth to 72 completed hours of age
    • Time frameother outcomeMaternal outcomes - post-surgery infectionBirth to one month → From delivery to 1 week postpartum
    • Descriptionother outcomeMaternal outcomes - maternal death: how it is measured was reworded
    • Descriptionother outcomeMaternal outcomes - post-surgery infection: how it is measured was reworded
    • Descriptionother outcomeNeonatal outcome - hyperbilirubinemia and jaundice: how it is measured was reworded
    + 3 other changes: verification date, description and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06540222
Lead sponsor
Region Skane
Collaborators
Region Stockholm
Responsible party
Sponsor
First posted
Aug 6, 2024
Start date
Sep 8, 2025
Primary completion
Nov 2027 (estimated)
Completion
Nov 2031 (estimated)
Last update
Oct 29, 2026

Study contacts

Ola Andersson, MD PhD
Contact
ola.andersson@med.lu.se
‭+46 70-966 41 80
Jenny Svedenkrans, MD PhD
Contact
jenny.svedenkrans@ki.se
‭+46 72-469 86 60
Ola Andersson, MD PhD
principal investigator · Region Skåne, Lund University
Jenny Svedenkrans, MD PhD
principal investigator · Karolinska University Hospital, Karolinska Institutet

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion